The Limpet is a single-use device intended for effluent management and promotion of
healing of intact and injured skin surrounding enterocutaneous fistulae and ostomies.
Our study focuses on small bowel openings, encompassing two important cohorts: 1)
ileostomy and 2) enterocutaneous fistulas (ECFs). Our study's success criterion is
primarily based on the pooled results from both cohorts.
Primary Hypothesis 1: Peristomal Skin Complications (PSCs): We hypothesize that the
Limpet will demonstrate a significant improvement in PSCs compared to standard of care
adhesive ostomy pouches. Specifically, we anticipate a raw difference of 35% in PSCs for
the pooled cohorts, with a complication rate of 50% in the control group and 15% in the
Limpet group.
Primary Hypothesis 2: Dressing Leak Rates: We hypothesize that the Limpet will
demonstrate a significant improvement in dressing leak rates compared to standard of care
adhesive ostomy pouches. Specifically, we anticipate a raw difference of 15% in leak
rates for the pooled cohorts, with a leak rate of 30% in the control group and 15% in the
Limpet group.
These hypotheses are grounded in existing literature, supplemented by clinical
experience. We intend to conduct subgroup analyses to assess the treatment effect across
the two cohorts (ileostomy and ECF) and across other relevant subgroups such as gender,
race, etc.
Secondary Hypothesis: Total Complications (PSCs and Stomal Complications): We hypothesize
that the Limpet will exhibit a raw difference of 35% in total complications (comprising
PSCs and stomal complications like mucocutaneous separation and stoma retraction) for the
ileostomy cohort. Stoma complication rates vary widely in the literature, and we plan to
conduct sub analyses to evaluate the Limpet's effect on stoma complications independent
of PSCs.
This will be a 30 day, single-site, randomized controlled trial (RCT) for a
non-significant risk device, Limpet.
The study will have a two-arm parallel group design:
Ninety-two participants (78 stoma and 14 enterocutaneous fistula participants) will be
randomized after they have consented to study participation. Initial randomization will
occur in a 1:1 ratio (Limpet and Control). Participants will be randomly stratified with
permuted blocks by BMI (≤ vs > 40) and stoma type (loop ileostomy, end ileostomy, or
enterocutaneous fistula) to account differences in healing and wound severity.
This study will be conducted at HealthPartners Institute's Regions Hospital in St. Paul,
Minnesota. Data compiled by the Wound, Ostomy, and Continence Nursing Department reveals
an annual pool of more than 300 eligible patients at Regions Hospital.
The study will consist of the following visits:
Visit C1 (Day -35 to -6): Screening in-person clinic visit
Visit C2, Day 1: Baseline appointment clinic visit
Visit C3, Week 1: Clinic visit
Visit C4, Week 2: Clinic visit
Visit C5, Week 3: Clinic visit
Visit C6, Week 4: Final appointment during treatment period; clinic visit
After the Baseline Data Collection Period, participants will be randomized by BMI and
three stoma types: ileostomy with loop stoma, ileostomy with end stoma, and
enterocutaneous fistulas (ECFs) into 1 of 2 treatment groups:
On Day 1, Limpet participants will have their device placed by a clinician. Upon
discharge, a portable vacuum pump will be issued to provide negative pressure (e.g., 3M
Prevena or Snap; ConvaTec Avelle; or Pensar MicroDoc). These systems are compact, fit in
a pocket, are simple to operate, and commonly used in the outpatient setting to provide
multiple weeks of therapy. Participants will be furnished with materials to address
potential dressing problems while at home: extra waste pouches, adhesive drape strips for
sealing air leaks, and standard of care adhesive ostomy pouches and accessories as a
backup plan in the event of a Limpet failure.
On Day 1, Control participants will receive standard of care adhesive ostomy pouch
dressings. Participants will be furnished with materials to address potential dressing
problems while at home: adhesive ostomy pouches and accessories for pouch replacement.
The Control group will change their pouches at home 2 to 5 times per week or more
frequently if needed, as per the current standard of care.
The brand and model of pumps and adhesive ostomy pouches used by Limpet and Control
participants will be recorded for comparison purposes. Participants will return for
clinic visits approximately every 7 days to have their device replaced. Participants will
have their final study appointment approximately 30 days post-surgery. Clinical support
will help the participant troubleshoot dressing problems; and if necessary, bring the
patient into the study site for an immediate dressing change.